AU2003292720A8 - Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same - Google Patents

Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Info

Publication number
AU2003292720A8
AU2003292720A8 AU2003292720A AU2003292720A AU2003292720A8 AU 2003292720 A8 AU2003292720 A8 AU 2003292720A8 AU 2003292720 A AU2003292720 A AU 2003292720A AU 2003292720 A AU2003292720 A AU 2003292720A AU 2003292720 A8 AU2003292720 A8 AU 2003292720A8
Authority
AU
Australia
Prior art keywords
dihydrothienoquinoline
derivatives
same
cell adhesion
adhesion inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292720A
Other versions
AU2003292720A1 (en
Inventor
Munetada Haruyama
Reiko Kamei
Kenji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of AU2003292720A1 publication Critical patent/AU2003292720A1/en
Publication of AU2003292720A8 publication Critical patent/AU2003292720A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2003292720A 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same Abandoned AU2003292720A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-378087 2002-12-26
JP2002378087A JP2006151810A (en) 2002-12-26 2002-12-26 Dihydrothienoquinoline derivative and cell adhesion inhibitor containing the same
PCT/JP2003/017063 WO2004058772A1 (en) 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Publications (2)

Publication Number Publication Date
AU2003292720A1 AU2003292720A1 (en) 2004-07-22
AU2003292720A8 true AU2003292720A8 (en) 2004-07-22

Family

ID=32677415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292720A Abandoned AU2003292720A1 (en) 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Country Status (3)

Country Link
JP (1) JP2006151810A (en)
AU (1) AU2003292720A1 (en)
WO (1) WO2004058772A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200634019A (en) * 2004-12-21 2006-10-01 Wyeth Corp Thienoisoquinoline-phenylsulfonamides and their use as er-nfkb inhibitors
TW200813054A (en) * 2006-06-02 2008-03-16 Elan Pharm Inc Fused, tricyclic sulfonamide inhibitors of gamma secretase
CA2682733A1 (en) * 2007-04-13 2008-10-23 Supergen, Inc. Axl kinase inhibitors
JP4719317B2 (en) 2008-02-26 2011-07-06 武田薬品工業株式会社 Fused heterocyclic derivatives and uses thereof
ES2671748T3 (en) 2011-07-21 2018-06-08 Tolero Pharmaceuticals, Inc. Heterocyclic protein kinase inhibitors
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
BR112020020246A8 (en) 2018-04-05 2022-10-18 Sumitomo Dainippon Pharma Oncology Inc AXL KINASE INHIBITORS AND THEIR USE
CN108623613A (en) * 2018-04-24 2018-10-09 哈尔滨工业大学（威海） A kind of preparation method and application of nitrogenous, sulphur fused ring compound
CA3127502A1 (en) 2019-02-12 2020-08-20 Sumitomo Dainippon Pharma Oncology, Inc. Formulations comprising heterocyclic protein kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504702D0 (en) * 1985-02-23 1985-03-27 Zyma Sa Tricyclic compounds
JP2997828B2 (en) * 1992-07-30 2000-01-11 株式会社大塚製薬工場 Quinoline and naphthyridine derivatives
JP2003518039A (en) * 1999-12-21 2003-06-03 アストラゼネカ アクチボラグ CD45 inhibitor

Also Published As

Publication number Publication date
AU2003292720A1 (en) 2004-07-22
JP2006151810A (en) 2006-06-15
WO2004058772A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
AU2003202263A1 (en) Roh-kinase inhibitors
AU6903200A (en) Heterocycle amides as cell adhesion inhibitors
EP1519431A4 (en) Electrode and cell comprising the same
GB0205527D0 (en) Inhibitors
AU2003300832A1 (en) NF-KappaB INHIBITORS
EP1547451A4 (en) Cell adhesion resisting surfaces
AU2003284001A8 (en) Triazolone and triazolethione derivatives
AU2003268033A8 (en) Systems and methods for cell preservation
AU2003271437A1 (en) Arylglycine derivatives and their use as glycine transport inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU3716499A (en) Substituted diamines and their use as cell adhesion inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003241392A1 (en) Package with pocket and method for making the same
GB0017279D0 (en) Amides as cell adhesion inhibitors
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003292720A8 (en) Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same
AU2003211520A1 (en) Lfa-1 inhibitors and use thereof
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003222058A1 (en) Materials and methods for inhibiting wip-1
AU2003224941A1 (en) NF-KappaB INHIBITORS
AU2003210741A1 (en) Ptpase inhibitors and methods of using the same
TW549609U (en) Terminal and battery containing the same

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 33, PAGE(S) 8616 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME DAIICHI SUNTORY PHARMA CO.,LTD., APPLICATION NO. 2003292720, UNDER INID (71) CORRECT THE NAME TO READ DAIICHI SUNTORY PHARMA CO.,LTD.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase